Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions-Reference-Cited by-同舟云学术

Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions

Published:2015-02-27 Issue:6 Volume:55 Page:1195-1205
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Bruhn Roberta¹,Lelie Nico²,Busch Michael¹,Kleinman Steven³,

Affiliation:

1. Blood Systems Research Institute; San Francisco California

2. Lelie Research; Paris France

3. University of British Columbia; Victoria British Columbia Canada

Funder

Grifols Diagnostics, Inc.

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.13024/fullpdf

Reference18 articles.

1. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009;Roth;Vox Sang,2012

2. Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan;Moiz;Transfusion,2014

3. Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios;Bruhn;Transfusion,2013

4. Prevalence of HBV infection in six geographical regions and clinical sensitivity of HBsAg and HBV-DNA screening;Lelie;Vox Sang,2013

5. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios;El Ekiaby;Transfusion,2015

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infectivity of Hepatitis B Virus Surface Antigen‐Positive Plasma With Undetectable HBV‐DNA: Can HBsAg Screening Be Discontinued in Egyptian Blood Donors?;Journal of Viral Hepatitis;2024-08-10

2. Chronic liver disease after allogeneic hematopoietic cell transplantation;Cytotherapy;2024-07

3. Prevalence, incidence, risk factors and residual risk associated with viral infections among eligible Brazilian blood donors;Transfusion Medicine;2024-01-02

4. Development and clinical validation of a one-step pentaplex real-time reverse transcription PCR assay for detection of hepatitis virus B, C, E, Treponema pallidum, and a human housekeeping gene;BMC Infectious Diseases;2023-05-25

5. Is dual testing for hepatitis C necessary? Modelling the risk of removing hepatitis C antibody testing for Australian blood donations;Vox Sanguinis;2023-05-14